It is well known that bisphosphonates, as antiresorptive drugs, are excellent for the treatment of pathologies involving bone loss, such as osteoporosis, breast cancer, to mention the best known. However, there are consequences for the chronic use of this medication; this work represents a summary of the medical specialists who use it in different bone pathologies, and the most common consequences that occur.